| http://purl.uniprot.org/citations/19148489 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/19148489 | http://www.w3.org/2000/01/rdf-schema#comment | "We previously reported the SART3 gene to be a tumor-rejection antigen gene encoding a peptide at positions 109-118 (SART3(109-118)) with the ability to induce HLA-A24-restricted cytotoxic T lymphocytes. In this study, we investigated both humoral and cellular responses to this peptide in cancer patients with alleles other than HLA-A24 to explore the possibility of using this peptide as a cancer vaccine for these patients. IgG reactive to SART3(109-118) peptide was identified in sera of the vast majority of non-cancer subjects (n=50) and all cancer patients (n=50) tested without apparent HLA-A association. Levels of anti-SART3(109-118) peptide antibody in cancer patients were significantly higher than those of non-cancer subjects, but no difference was found between HLA-A24+A2- and HLA-A24-A2+ cancer patients. This peptide induced cancer cell-reactive cytotoxic T lymphocytes from peripheral blood mononuclear cells of both healthy donors and prostate cancer patients with HLA-A11, HLA-A31 and HLA-A33 alleles, but not with HLA-A2. These results suggest that this peptide can be applicable as a cancer vaccine not only for HLA-A24+, but also for HLA-A11+, HLA-A31+ and HLA-A33+ prostate cancer patients."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/author | "Itoh K."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/author | "Niu Y."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/author | "Naito M."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/author | "Shichijo S."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/author | "Noguchi M."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/author | "Komatsu N."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/author | "Terasaki Y."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/author | "Gohara S."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/author | "Mohamed E.R."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/date | "2009"xsd:gYear |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/name | "Int J Oncol"xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/pages | "529-536"xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/title | "Capability of SART3(109-118) peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11, -A31 and -A33 alleles."xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://purl.uniprot.org/core/volume | "34"xsd:string |
| http://purl.uniprot.org/citations/19148489 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/19148489 |
| http://purl.uniprot.org/citations/19148489 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/19148489 |
| http://purl.uniprot.org/uniprot/#_A0A0A7C548-mappedCitation-19148489 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/19148489 |
| http://purl.uniprot.org/uniprot/#_A0A0A7C551-mappedCitation-19148489 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/19148489 |
| http://purl.uniprot.org/uniprot/#_A0A0G2R0N3-mappedCitation-19148489 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/19148489 |
| http://purl.uniprot.org/uniprot/#_A0A0G2R0N4-mappedCitation-19148489 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/19148489 |
| http://purl.uniprot.org/uniprot/#_A0A0G2R0N5-mappedCitation-19148489 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/19148489 |
| http://purl.uniprot.org/uniprot/#_A0A076JXB7-mappedCitation-19148489 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/19148489 |
| http://purl.uniprot.org/uniprot/#_A0A076L0P9-mappedCitation-19148489 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/19148489 |